1.
Cancers (Basel)
; 16(8)2024 Apr 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38672681
RESUMO
This review addresses interferon (IFN) signaling in immune cells and the tumor microenvironment (TME) and examines how this affects cancer progression. The data reveal that IFNs exert dual roles in cancers, dependent on the TME, exhibiting both anti-tumor activity and promoting cancer progression. We discuss the abnormal IFN signaling induced by cancerous cells that alters immune responses to permit their survival and proliferation.